Malaysia set to become Hepatitis C treatment hub of Asia

insigHT2021, Malaysia’s medical travel market intelligence conference, featured the launch of Malaysia as the Hepatitis C Treatment Hub of

Asia by Minister of Health Malaysia, Yang Berhormat Khairy Jamaluddin. Being the first country in the world to be given conditional approval for Ravidasvir in combination with Sofosbuvir to treat Hepatitis C, Malaysia is poised to offer access to an affordable and efficacious treatment solution for those infected with the virus. In response to the World Hepatitis Day 2021 theme, ‘Hepatitis Can’t Wait’, Malaysia is ready and raring to move forward with a treatment solution for those infected with the disease. This is in line with WHO’s mission to reduce new viral hepatitis infections by 90 per cent and reduce deaths by viral hepatitis by 65 per cent by 2030. Malaysia is offering Hepatitis C patients a treatment with a cure rate of 97 per cent and cost reduction of 95 per cent.